What is BioPro?
BioPro Implants, established in 1987, is dedicated to the design and manufacturing of orthopedic implants and devices. Their product portfolio aims to alleviate pain and restore function for patients facing various orthopedic conditions, including arthritis, bunions, and flatfoot. The company offers a comprehensive range of solutions, encompassing foot, ankle, hand, and wrist issues, alongside biologics and total joint systems. BioPro serves orthopedic surgeons seeking reliable implant solutions and patients in need of both time-tested and innovative orthopedic technologies.
How much funding has BioPro raised?
BioPro has raised a total of $747K across 2 funding rounds:
Debt
$350K
Debt
$397K
Debt (2020): $350K with participation from PPP
Debt (2021): $397K led by PPP
Key Investors in BioPro
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for BioPro?
With a history of substantial enterprise-level funding, BioPro is strategically positioned for continued expansion and innovation in the orthopedic market. The recent major strategic investment signals a phase of accelerated growth, likely focused on enhancing product development, expanding market reach, and potentially exploring new technological advancements in implant design and biologics. This capital infusion will be critical in solidifying BioPro's commitment to quality and innovation, further enabling them to address the evolving needs of patients and healthcare providers in the orthopedic field.
See full BioPro company page
